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be particularly susceptible to oxidative
damage during aging. Finally, what are
the consequences, if any, of variable
heart cell gene expression for the mouse?
Mice heterozygous for null mutations
in the mitochondrial antioxidant MnSOD
have increased oxidative stress and
increased oxidative damage to nuclear
DNA in the heart and other tissues,
yet a normal life span (Van Remmen
et al., 2003). It would be interesting to
see if these mice have increased variabil-
ity in cardiomyocyte gene expression. It
may be that tissues can tolerate a signifi-
cant cell-to-cell variability in gene ex-
pression without obvious phenotypic
consequences. Finally, RNA levels are
regulated by both synthesis and degra-
dation, meaning that increased variability
could be caused either at the level of
transcription, or at the level of RNA
turnover, and it will be important to dis-
tinguish between these possibilities in
the future.
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P R E V I E W SDirty dealing: Hepatic vagal afferents reshuffle
fat distribution
To evaluate the role of hepatic peroxisome-proliferator-activated receptor (PPAR) g 2 in the control of energy balance, Uno
and colleagues examined the metabolic effects of overexpression of PPAR g 2 selectively in mouse and rat liver. Mice dem-
onstrated a surprising degree of hepatic steatosis accompanied by significant reductions in peripheral adiposity. This cross-
talk between liver and adipose tissue appears to bemediated by both the sensory component of the hepatic vagus nerve and
sympathetic efferents. These data suggest a novel hepatic-adipose neuraxis that regulates the distribution of stored fat.Metabolic events have long been charac-
terized as modulators of multiple aspects
of energy homeostasis. Alterations in the
availability of nutrients selectively pro-
vided to the hepatic portal system po-
tently modulate food intake and glucose
homeostasis (Berthoud, 2004; Hevener
et al., 2001). The idea that metabolic
events within the liver have ramifications
for distal organ systems involved in de-
termining energy balance has driven
experiments designed to identify and
characterize sufficient nutrient feedback
signals that affect multiple homeostatic
behavioral and physiological responses.
What are these signals and how do they
exert their effects on distant organs? Re-
cent work by Uno and collegaues (Uno
et al., 2006) demonstrate a novel role
for hepatic PPAR g in modulating fat dis-
tribution that appears to rely on sensoryCELL METABOLISM : AUGUST 2006neural communication between the liver
and the brain.
In rodents, the hepatic vagus nerve is
the sole branch that supplies the hepatic
portal vein. There is no neuoranatomical
evidence supporting the direct sensory
innervation of the hepatic parenchyma
itself. (Berthoud, 2004). As a mixed nerve,
it carries both sensory (afferent) fibers
from the hepatic portal vein adventitia to
the brainstem nucleus of the solitary tract,
and cholinergic motorneurons arising in
the dorsal motor vagal nucleus of the
brainstem projecting to the liver. The lat-
ter have been shown to play a vital role
in modulating rapid counterregulatory
changes in glucose production following
alterations in hypothalamic nutrient avail-
ability (Pocai et al., 2005; Lamet al., 2005).
From a sensory perspective, multiple
neurophysiological studies demonstratethat hepatic vagal afferents are respon-
sive to reduced portal glucose availability
and increased fatty acid availability, while
forebrain and hindbrain neuronal acti-
vation elicited by these compounds is
blocked by hepatic vagotomy or periva-
gal capsaicin treatment, which destroys
a subpopulation of unmyelinated sensory
fibers within the vagus. Consistent with
a functional role for these sensory capa-
bilities, inhibition of fatty acid oxidation
or infusion of glucopenic agents, such as
2-deoxyglucose, rapidly alters food in-
take to adjust to the locally perceived
changes in nutrient availability.
Peroxisome proliferator-activated re-
ceptors (PPARs) are transcription factors
that are part of the superfamily of nuclear
receptors. Three PPAR isoforms (a, delta,
and g) have been identified. PPAR-g is
expressed primarily in adipose tissue103
P R E V I E W SFigure 1. The afferent portion of the hepatic branch of the vagus nerve has been demonstrated to convey sig-
nals relating to nutrient availability to hindbrain and forebrain neurons important in the control of energy bal-
ance
Alterations in local nutrient availability modulate hepatic vagal afferent signaling to the brain. Uno et al. (2006)
demonstrate that this pathway is also important for reductions in WAT and BAT observed following selective
hepatic PPAR g 2 overexpression and suggest that sympathetic outflow to adipoctyes from the central ner-
vous system mediates these effects. This figure depicts a schematic of the suggested components in this he-
patic-adipose neuraxis.and muscle as well as modestly in
liver, and their natural ligands are fatty
acids and lipid-derived substrates. Acti-
vation of PPAR-g stimulates multiple
genes involved in lipid metabolism and
lipogenesis, induces the differentiation of
preadipocytes into adipocytes, and stim-
ulates triglyceride storage. In addition,
PPAR g activation alters the expression
of both gluconeogenic and glycogeno-
lytic enzymes to improve glucose homeo-
stasis, and ameliorates peripheral insulin
sensitivity.
Recent work of Gavrilova and col-
leagues has shown that liver PPAR g pro-
duces hepatic steatosis, but protects
nonhepatic tissues against insulin resis-
tance and lipid accumulation (Gavrilova
et al., 2003). In addition, high fat-induced
liver steatosis is accompanied by ele-
vated hepatic PPAR g (Inoue et al.,
2005), and is elevated in other rodent
models of obesity. Consequently, Uno
and colleagues used injectable adeno-
virus vectors to examine the metabolic
consequences of liver specific PPAR g104overexpression in diabetes induced by
high fat feeding. Three days after adeno-
virus administration, they demonstrated
significant metabolic changes, including
marked reductions in insulin, leptin,
blood glucose, white adipose tissue
(WAT) weight and reduced brown adi-
pose tissue (BAT) cell diameter, and im-
proved peripheral insulin sensitivity.
These changes, however, were accom-
panied by increases in plasma free fatty
acids (FFA), liver weight, hepatic steato-
sis, hepatic triglyceride content, and de-
creased hepatic insulin sensitivity.
To begin to investigate the neurobiolog-
ical mechanisms underlying the distant
effects of liver PPAR g expression on adi-
pose tissue, Uno et al. (2006) interrupted
liver-brain communication by perform-
ing selective hepatic branch vagotomy.
This manipulation significantly reversed
the reductions in adiposity seen in intact
animals. Importantly, hepatic vagotomy
alone was without effect on adiposity, liver
weight or hepatic triglycerides in animals
injected with the LacZ control adenovirus.To discriminate between the possible
confound arising from transection of both
hepatic afferents and hepatic vagal
branch efferents inherent in the total he-
patic branch vagotomy, the authors ele-
gantly applied the neurotoxin capsaicin
to the hepatic vagus in rats. This treatment
preferentially destroys a subpopulation of
unmyelinated afferent fibers, while leav-
ing myelinated efferents intact. Noncap-
saicin-sensitive afferent fibers survive
following such treatment, but in this case
capsaicin treatment alone completely
recapitulated the effects of the complete
surgical hepatic branch vagotomy. The
neuroanatomicaly selectivity of these ef-
fects is also supported by the finding
that adjacent nonhepatic vagal branches
running along the esophagus were unaf-
fected by this treatment. Together, these
results strongly support their conclusion
that a subpopulation of hepatic branch
vagal afferents modulate some metabolic
responses to hepatic PPAR g 2 expres-
sion. It remainsunclearwhethersuchdeaf-
ferentation modulates the hepatic steato-
sis resulting from liver specific PPAR g
overexpression—total hepatic branch va-
gotomy failed to alter hepatic steatosis.
Systemic administration of a nonspe-
cific b adrenergic blocker prevented the
effects of liver PPARgamma-induced el-
evations in serum FFA, suggesting that
sympathetic efferents are critical for the
adipose effects observed (Figure 1). The
nature of the signal(s) generated by he-
patic PPAR g expression is certainly one
of the most intriguing aspects of the
present study. Either the observed in-
crease in plasma FFA or the decrease in
blood glucose elicited by liver PPAR g
expression may alter the activity of the
afferent hepatic vagus to in turn modu-
late sympathetic outflow to adipose tis-
sue. The central nervous systems site or
sites of crosstalk between ascending va-
gal signals and sympathetic outflow neu-
rons in this process remain to be identi-
fied. In this regard, hepatic portal vein
infusion of pharmacological stimuli that
modulate hepatic nutrient availability
also activate multiple populations of neu-
rons distributed throughout forebrain and
hindbrain sites. These include the brain-
stem nucleus of the solitary tract (NTS),
the first central nervous system termi-
nus for ascending metabolic information
from the liver, and the paraventricular
hypothalamic nucleus, important in mod-
ulating sympathetic outflow. Ascending
neuroanatomical projections from the NTSCELL METABOLISM : AUGUST 2006
P R E V I E W Sto the multiple hypothalamic sites in-
volved in determining sympathetic tone
have been demonstrated, and these may
be candidate neural substrates in medi-
ating vagal-sympathetic communication
within the CNS.
The neuroanatomy and neurochemis-
try of brown and white adipose tissue is
still in its infancy, with much unknown
about the neural pathways and signaling
mechanisms that mediate the regulation
of adipose tissue differentiation, prolifer-
ation and maintenance. Controversial re-
cent publications suggest that in addition
to sympathetic inputs, vagal efferents
also supply white adipose tissue (Kreier
et al., 2002, 2006; although see Giordano
et al., 2006, for contrast), while the major
brown fat depot, interscapular brown
adipose tissue (IBAT), appears to be
supplied primarily by sympathetic pre-
motor neurons within the brainstem
raphe nucleus (Morrison, 2004). Deter-
mining the neuroanatomical connectivity
between these adipose-projecting neu-
rons and hepatic-recipient NTS neurons
would be and an important step in devel-
oping the proposed neural circuitry
mediating PPAR g induced changes in
BAT. Because BAT and WAT have dis-
tinct neural pathways that mediate their
function, a neuroanatomical interpreta-
tion of the present data suggests that he-
patic vagal afferent signals diverge afterCELL METABOLISM : AUGUST 2006they reach the CNS to access multiple
neuronal pools driving different adipose
depots. Furthermore, the efferent neural
outflow specific to adipose tissue in par-
ticular requires separate study, as gen-
eral systemic b adrenergic blockade
likely generates nonspecific effects on
energy balance. Along these lines, it will
be important to identify and characterize
the ways in which fat pat specific neural
innervation modulates the role of liver
metabolism in regulating adiposity. Fi-
nally, hypothalamic PVN sites that are
part of the neural circuitry supplying adi-
pose tissue also likely communicate with
nutrient sensing sites in the mediobasal
hypothalmus, raising the larger possi-
bility that PPAR g expression-induced
changes in central nutrient availability
modulate its effects on adiposity.
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